Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 11,500 shares at $53.66 ($611K) on 2020-01-15, disclosed to the SEC on 2020-01-17.
Open-market sale of $611k TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.03 | 9,900 | $525K | 85.9% |
| 2 | $53.66 | 1,600 | $86K | 14.1% |
| Total | $53.12 avg | 11,500 | $611K | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |